{"entity":{"type":"insider","cik":"0001383731","url":"/insider/0001383731","json_url":"/insider/0001383731.json","name":"MacLean Michael F","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":41,"n_filings":21,"first":"2008-04-10","last":"2026-01-23","span_basis":"filed_date"},"name_variants":[{"name":"MacLean Michael F","source":"filing","n_filings":21,"first_seen":"2008-04-10","last_seen":"2026-01-23"}],"transactions":[{"id":5882143,"accession":"0001599901-26-000023","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001599901-26-000023","line_url":"/filing/0001599901-26-000023","is_derivative":false,"issuer_cik":"0001383731","issuer_name":"Avidity Biosciences, Inc.","issuer_ticker":"RNA","issuer_name_source":null,"issuer_url":"/issuer/0001383731","owner_cik":"0001383731","owner_name":"MacLean Michael F","owner_display_name":"MacLean Michael F","owner_url":"/insider/0001383731","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4542.0,"shares_display":"4,542","price_per_share":72.45,"price_display":"72.45","price_state":"stated","total_value":329067.9,"total_display":"329,067.90","total_whole":"329,068","shares_owned_after":59290.0,"shares_owned_after_display":"59,290","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-21","filed_date":"2026-01-23","scope":"insider","n_lines":2},{"id":6213696,"accession":"0001599901-26-000010","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001599901-26-000010","line_url":"/filing/0001599901-26-000010#line-1","is_derivative":false,"issuer_cik":"0001383731","issuer_name":"Avidity Biosciences, Inc.","issuer_ticker":"RNA","issuer_name_source":null,"issuer_url":"/issuer/0001383731","owner_cik":"0001383731","owner_name":"MacLean Michael F","owner_display_name":"MacLean Michael F","owner_url":"/insider/0001383731","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1974.0,"shares_display":"1,974","price_per_share":72.23,"price_display":"72.23","price_state":"stated","total_value":142582.02,"total_display":"142,582.02","total_whole":"142,582","shares_owned_after":63832.0,"shares_owned_after_display":"63,832","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-07","filed_date":"2026-01-09","scope":"insider"},{"id":4365746,"accession":"0001599901-25-000161","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001599901-25-000161","line_url":"/filing/0001599901-25-000161#line-1","is_derivative":false,"issuer_cik":"0001383731","issuer_name":"Avidity Biosciences, Inc.","issuer_ticker":"RNA","issuer_name_source":null,"issuer_url":"/issuer/0001383731","owner_cik":"0001383731","owner_name":"MacLean Michael F","owner_display_name":"MacLean Michael F","owner_url":"/insider/0001383731","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30914.0,"shares_display":"30,914","price_per_share":42.7264,"price_display":"42.73","price_state":"stated","total_value":1320843.9296,"total_display":"1,320,843.93","total_whole":"1,320,844","shares_owned_after":65806.0,"shares_owned_after_display":"65,806","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-06","filed_date":"2025-08-15","scope":"insider"},{"id":4927950,"accession":"0001599901-25-000069","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001599901-25-000069","line_url":"/filing/0001599901-25-000069#line-1","is_derivative":false,"issuer_cik":"0001383731","issuer_name":"Avidity Biosciences, Inc.","issuer_ticker":"RNA","issuer_name_source":null,"issuer_url":"/issuer/0001383731","owner_cik":"0001383731","owner_name":"MacLean Michael F","owner_display_name":"MacLean Michael F","owner_url":"/insider/0001383731","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7935.0,"shares_display":"7,935","price_per_share":31.0554,"price_display":"31.06","price_state":"stated","total_value":246424.599,"total_display":"246,424.60","total_whole":"246,425","shares_owned_after":96720.0,"shares_owned_after_display":"96,720","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-20","filed_date":"2025-03-21","scope":"insider"},{"id":4032455,"accession":"0001599901-25-000041","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001599901-25-000041","line_url":"/filing/0001599901-25-000041","is_derivative":false,"issuer_cik":"0001383731","issuer_name":"Avidity Biosciences, Inc.","issuer_ticker":"RNA","issuer_name_source":null,"issuer_url":"/issuer/0001383731","owner_cik":"0001383731","owner_name":"MacLean Michael F","owner_display_name":"MacLean Michael F","owner_url":"/insider/0001383731","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3287.0,"shares_display":"3,287","price_per_share":28.59305196227563,"price_display":"28.59","price_state":"stated","total_value":93985.3618,"total_display":"93,985.36","total_whole":"93,985","shares_owned_after":104655.0,"shares_owned_after_display":"104,655","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-21","filed_date":"2025-01-23","scope":"insider","n_lines":2},{"id":2290525,"accession":"0001599901-24-000206","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001599901-24-000206","line_url":"/filing/0001599901-24-000206#line-1","is_derivative":false,"issuer_cik":"0001383731","issuer_name":"Avidity Biosciences, Inc.","issuer_ticker":"RNA","issuer_name_source":null,"issuer_url":"/issuer/0001383731","owner_cik":"0001383731","owner_name":"MacLean Michael F","owner_display_name":"MacLean Michael F","owner_url":"/insider/0001383731","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11151.0,"shares_display":"11,151","price_per_share":32.66,"price_display":"32.66","price_state":"stated","total_value":364191.66,"total_display":"364,191.66","total_whole":"364,192","shares_owned_after":82942.0,"shares_owned_after_display":"82,942","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-18","filed_date":"2024-12-19","scope":"insider"},{"id":2063420,"accession":"0001599901-24-000188","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001599901-24-000188","line_url":"/filing/0001599901-24-000188","is_derivative":false,"issuer_cik":"0001383731","issuer_name":"Avidity Biosciences, Inc.","issuer_ticker":"RNA","issuer_name_source":null,"issuer_url":"/issuer/0001383731","owner_cik":"0001383731","owner_name":"MacLean Michael F","owner_display_name":"MacLean Michael F","owner_url":"/insider/0001383731","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":106319.0,"shares_display":"106,319","price_per_share":45.560803411431635,"price_display":"45.56","price_state":"stated","total_value":4843979.0579,"total_display":"4,843,979.06","total_whole":"4,843,979","shares_owned_after":94093.0,"shares_owned_after_display":"94,093","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-06","filed_date":"2024-11-08","scope":"insider","n_lines":3},{"id":3057449,"accession":"0001599901-24-000156","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001599901-24-000156","line_url":"/filing/0001599901-24-000156#line-3","is_derivative":false,"issuer_cik":"0001383731","issuer_name":"Avidity Biosciences, Inc.","issuer_ticker":"RNA","issuer_name_source":null,"issuer_url":"/issuer/0001383731","owner_cik":"0001383731","owner_name":"MacLean Michael F","owner_display_name":"MacLean Michael F","owner_url":"/insider/0001383731","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11510.0,"shares_display":"11,510","price_per_share":44.0,"price_display":"44.00","price_state":"stated","total_value":506440.0,"total_display":"506,440.00","total_whole":"506,440","shares_owned_after":96355.0,"shares_owned_after_display":"96,355","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-23","filed_date":"2024-09-23","scope":"insider"},{"id":3186182,"accession":"0001599901-24-000110","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001599901-24-000110","line_url":"/filing/0001599901-24-000110#line-3","is_derivative":false,"issuer_cik":"0001383731","issuer_name":"Avidity Biosciences, Inc.","issuer_ticker":"RNA","issuer_name_source":null,"issuer_url":"/issuer/0001383731","owner_cik":"0001383731","owner_name":"MacLean Michael F","owner_display_name":"MacLean Michael F","owner_url":"/insider/0001383731","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11228.0,"shares_display":"11,228","price_per_share":39.1294,"price_display":"39.13","price_state":"stated","total_value":439344.9032,"total_display":"439,344.90","total_whole":"439,345","shares_owned_after":57865.0,"shares_owned_after_display":"57,865","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-18","filed_date":"2024-06-20","scope":"insider"},{"id":2511354,"accession":"0001599901-24-000101","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001599901-24-000101","line_url":"/filing/0001599901-24-000101#line-2","is_derivative":false,"issuer_cik":"0001383731","issuer_name":"Avidity Biosciences, Inc.","issuer_ticker":"RNA","issuer_name_source":null,"issuer_url":"/issuer/0001383731","owner_cik":"0001383731","owner_name":"MacLean Michael F","owner_display_name":"MacLean Michael F","owner_url":"/insider/0001383731","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":104245.0,"shares_display":"104,245","price_per_share":35.7153,"price_display":"35.72","price_state":"stated","total_value":3723141.4485,"total_display":"3,723,141.45","total_whole":"3,723,141","shares_owned_after":44093.0,"shares_owned_after_display":"44,093","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-12","filed_date":"2024-06-14","scope":"insider"},{"id":2588183,"accession":"0000950170-24-061258","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-061258","line_url":"/filing/0000950170-24-061258#line-2","is_derivative":false,"issuer_cik":"0001383731","issuer_name":"Avidity Biosciences, Inc.","issuer_ticker":"RNA","issuer_name_source":null,"issuer_url":"/issuer/0001383731","owner_cik":"0001383731","owner_name":"MacLean Michael F","owner_display_name":"MacLean Michael F","owner_url":"/insider/0001383731","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75000.0,"shares_display":"75,000","price_per_share":28.2806,"price_display":"28.28","price_state":"stated","total_value":2121045.0,"total_display":"2,121,045.00","total_whole":"2,121,045","shares_owned_after":44093.0,"shares_owned_after_display":"44,093","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-14","filed_date":"2024-05-16","scope":"insider"},{"id":2192986,"accession":"0001599901-24-000044","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001599901-24-000044","line_url":"/filing/0001599901-24-000044#line-2","is_derivative":false,"issuer_cik":"0001383731","issuer_name":"Avidity Biosciences, Inc.","issuer_ticker":"RNA","issuer_name_source":null,"issuer_url":"/issuer/0001383731","owner_cik":"0001383731","owner_name":"MacLean Michael F","owner_display_name":"MacLean Michael F","owner_url":"/insider/0001383731","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":24.519,"price_display":"24.52","price_state":"stated","total_value":980760.0,"total_display":"980,760.00","total_whole":"980,760","shares_owned_after":44093.0,"shares_owned_after_display":"44,093","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-13","filed_date":"2024-03-15","scope":"insider"},{"id":2320077,"accession":"0001599901-24-000008","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001599901-24-000008","line_url":"/filing/0001599901-24-000008#line-2","is_derivative":false,"issuer_cik":"0001383731","issuer_name":"Avidity Biosciences, Inc.","issuer_ticker":"RNA","issuer_name_source":null,"issuer_url":"/issuer/0001383731","owner_cik":"0001383731","owner_name":"MacLean Michael F","owner_display_name":"MacLean Michael F","owner_url":"/insider/0001383731","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1616.0,"shares_display":"1,616","price_per_share":10.13,"price_display":"10.13","price_state":"stated","total_value":16370.08,"total_display":"16,370.08","total_whole":"16,370","shares_owned_after":16884.0,"shares_owned_after_display":"16,884","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-22","filed_date":"2024-01-23","scope":"insider"},{"id":7401983,"accession":"0001127602-10-020455","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001127602-10-020455","line_url":"/filing/0001127602-10-020455","is_derivative":false,"issuer_cik":"0000875045","issuer_name":"BIOGEN IDEC INC.","issuer_ticker":"BIIB","issuer_name_source":null,"issuer_url":"/issuer/0000875045","owner_cik":"0001383731","owner_name":"MacLean Michael F","owner_display_name":"MacLean Michael F","owner_url":"/insider/0001383731","role":"Officer (SVP, Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9542.0,"shares_display":"9,542","price_per_share":56.8493515615175,"price_display":"56.85","price_state":"stated","total_value":542456.5126,"total_display":"542,456.51","total_whole":"542,457","shares_owned_after":11634.4773,"shares_owned_after_display":"11,634.48","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-08-02","filed_date":"2010-08-03","scope":"insider","n_lines":7},{"id":9226810,"accession":"0001127602-10-011471","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-10-011471","line_url":"/filing/0001127602-10-011471#line-1","is_derivative":false,"issuer_cik":"0001383731","issuer_name":"BIOGEN IDEC INC.","issuer_ticker":"BIIB","issuer_name_source":null,"issuer_url":"/issuer/0001383731","owner_cik":"0001383731","owner_name":"MacLean Michael F","owner_display_name":"MacLean Michael F","owner_url":"/insider/0001383731","role":"Officer (SVP, Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3757.0,"shares_display":"3,757","price_per_share":60.0,"price_display":"60.00","price_state":"stated","total_value":225420.0,"total_display":"225,420.00","total_whole":"225,420","shares_owned_after":20641.9467,"shares_owned_after_display":"20,641.95","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-03-19","filed_date":"2010-04-20","scope":"insider"},{"id":7296854,"accession":"0001127602-10-009326","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-10-009326","line_url":"/filing/0001127602-10-009326#line-1","is_derivative":false,"issuer_cik":"0000875045","issuer_name":"BIOGEN IDEC INC.","issuer_ticker":"BIIB","issuer_name_source":null,"issuer_url":"/issuer/0000875045","owner_cik":"0001383731","owner_name":"MacLean Michael F","owner_display_name":"MacLean Michael F","owner_url":"/insider/0001383731","role":"Officer (SVP, Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4085.0,"shares_display":"4,085","price_per_share":60.0,"price_display":"60.00","price_state":"stated","total_value":245100.0,"total_display":"245,100.00","total_whole":"245,100","shares_owned_after":20313.9467,"shares_owned_after_display":"20,313.95","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-03-19","filed_date":"2010-03-23","scope":"insider"},{"id":7646787,"accession":"0001127602-10-001737","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-10-001737","line_url":"/filing/0001127602-10-001737#line-1","is_derivative":false,"issuer_cik":"0000875045","issuer_name":"BIOGEN IDEC INC.","issuer_ticker":"BIIB","issuer_name_source":null,"issuer_url":"/issuer/0000875045","owner_cik":"0001383731","owner_name":"MacLean Michael F","owner_display_name":"MacLean Michael F","owner_url":"/insider/0001383731","role":"Officer (SVP, Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1389.0,"shares_display":"1,389","price_per_share":55.0,"price_display":"55.00","price_state":"stated","total_value":76395.0,"total_display":"76,395.00","total_whole":"76,395","shares_owned_after":23260.9467,"shares_owned_after_display":"23,260.95","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-01-19","filed_date":"2010-01-19","scope":"insider"},{"id":2473412,"accession":"0001127602-08-007895","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-08-007895","line_url":"/filing/0001127602-08-007895#line-1","is_derivative":false,"issuer_cik":"0000875045","issuer_name":"BIOGEN IDEC INC.","issuer_ticker":"BIIB","issuer_name_source":null,"issuer_url":"/issuer/0000875045","owner_cik":"0001383731","owner_name":"MacLean Michael F","owner_display_name":"MacLean Michael F","owner_url":"/insider/0001383731","role":"Officer (SVP, Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2047.0,"shares_display":"2,047","price_per_share":50.0,"price_display":"50.00","price_state":"stated","total_value":102350.0,"total_display":"102,350.00","total_whole":"102,350","shares_owned_after":21894.6459,"shares_owned_after_display":"21,894.65","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-10-06","filed_date":"2008-10-06","scope":"insider"},{"id":3835702,"accession":"0001209191-08-044675","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-08-044675","line_url":"/filing/0001209191-08-044675#line-2","is_derivative":false,"issuer_cik":"0000875045","issuer_name":"BIOGEN IDEC INC.","issuer_ticker":"BIIB","issuer_name_source":null,"issuer_url":"/issuer/0000875045","owner_cik":"0001383731","owner_name":"MacLean Michael F","owner_display_name":"MacLean Michael F","owner_url":"/insider/0001383731","role":"Officer (SVP, Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1875.0,"shares_display":"1,875","price_per_share":72.77,"price_display":"72.77","price_state":"stated","total_value":136443.75,"total_display":"136,443.75","total_whole":"136,444","shares_owned_after":24894.6459,"shares_owned_after_display":"24,894.65","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-07-31","filed_date":"2008-08-01","scope":"insider"},{"id":4148817,"accession":"0001209191-08-043552","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-08-043552","line_url":"/filing/0001209191-08-043552#line-1","is_derivative":false,"issuer_cik":"0000875045","issuer_name":"BIOGEN IDEC INC.","issuer_ticker":"BIIB","issuer_name_source":null,"issuer_url":"/issuer/0000875045","owner_cik":"0001383731","owner_name":"MacLean Michael F","owner_display_name":"MacLean Michael F","owner_url":"/insider/0001383731","role":"Officer (SVP, Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":682.0,"shares_display":"682","price_per_share":70.0,"price_display":"70.00","price_state":"stated","total_value":47740.0,"total_display":"47,740.00","total_whole":"47,740","shares_owned_after":24894.6459,"shares_owned_after_display":"24,894.65","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-07-22","filed_date":"2008-07-24","scope":"insider"},{"id":2475319,"accession":"0001209191-08-023621","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001209191-08-023621","line_url":"/filing/0001209191-08-023621","is_derivative":false,"issuer_cik":"0000875045","issuer_name":"BIOGEN IDEC INC.","issuer_ticker":"BIIB","issuer_name_source":null,"issuer_url":"/issuer/0000875045","owner_cik":"0001383731","owner_name":"MacLean Michael F","owner_display_name":"MacLean Michael F","owner_url":"/insider/0001383731","role":"Officer (SVP, Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2214.0,"shares_display":"2,214","price_per_share":64.36656729900632,"price_display":"64.37","price_state":"stated","total_value":142507.58,"total_display":"142,507.58","total_whole":"142,508","shares_owned_after":26390.6459,"shares_owned_after_display":"26,390.65","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-04-08","filed_date":"2008-04-10","scope":"insider","n_lines":11}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":41,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":41,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":41},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001599901","name":"Avidity Biosciences, Inc.","url":"/issuer/0001599901","role":"Officer (Chief Financial Officer)","n_filings":13,"first_seen":"2024-01-23","last_seen":"2026-01-23"},{"type":"issuer","type_label":"ISSUER","cik":"0000875045","name":"BIOGEN IDEC INC.","url":"/issuer/0000875045","role":"Officer (SVP, Chief Accounting Officer)","n_filings":8,"first_seen":"2008-04-10","last_seen":"2010-08-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001383731","retrieved_at":"2026-08-26T07:22:13+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}